Tetricus Labs, a New Haven, CT- and NYC-based developer of a machine learning platform for use by both providers and patients to enhance the precision with which mental illness is diagnosed and treated, received a Seed investment from Research Bridge Partners.
The amount of the deal was not disclosed.
The company intends to use the funds to expand operations and its development efforts. The investment will fund the development of Tetricus Labs’ leadership team and support clinical trials involving the company’s machine learning platform. With this investment, Isaac Barchas, Research Bridge Partners Co-Founder and CEO, has joined the company’s board of directors.
Co-founded in 2022 by Lindsay Dow, Dr. Philip Corlett, and Dr. Sean McCurdy, Tetricus Labs provides a software platform that supports psychiatric hospitals and providers to comprehensively assess incoming referrals, match patients with the right type and level of treatment, and monitor patient outcomes to refine and optimize care over time.
Tetricus is a Yale University spinout.
FinSMEs
29/09/2023